Media Releases
Same purpose, stronger identity: mylife Diabetes Care takes next step as an independent diabetes care company
The new global identity reflects the company’s purpose and focus, while supporting the transition to mylife Diabetes Care AG as legal manufacturer.
Burgdorf, Switzerland, 1 June 2026 – mylife Diabetes Care today announced the next step in its evolution as an independent diabetes care company. With a renewed global corporate identity, the company is making its purpose, values and focus more visible across products, communications and stakeholder touchpoints worldwide.
The new identity reflects what has long guided mylife Diabetes Care: a clear purpose to make life with diabetes easier, a strong focus on innovative insulin delivery, and close collaboration with patients, healthcare professionals, partners and payers to support reliable diabetes care.
As part of this evolution, mylife Diabetes Care AG becomes the legal manufacturer for mylife products as of 1 June 2026. Products under the new legal manufacturer will be introduced to the market step by step starting from 1 July 2026.
The global identity will be introduced gradually across its markets, including updated product and company names, refreshed packaging and labelling, a new global website, and updated regulatory and legal manufacturer information.
“Our new identity reflects who we are today and what guides us going forward,” said Sébastien Delarive, Chief Executive Officer of mylife Diabetes Care. “Driven by science, engineering and dedication, we develop solutions that support people living with diabetes in everyday life, while maintaining the quality, safety and continuity that healthcare professionals, partners and users know and trust.”
Product names have been simplified to make the portfolio easier to navigate. For example, mylife Loop becomes myLoop, mylife YpsoPump becomes YpsoPump, and mylife YpsoPump Orbit infusion sets are now grouped under the myOrbit family.
The transition is designed to ensure continuity for healthcare professionals, partners, payers and people living with diabetes. Product equivalence and compatibility will remain unchanged, while a phased approach will support uninterrupted distribution. During the transition period, products bearing the name of the former legal manufacturer, Ypsomed AG, or the new legal manufacturer, mylife Diabetes Care AG, may remain in circulation temporarily.
The new global website is now available at www.mylife-diabetescare.com.
Disclaimer
The updated brand and product naming do not change product functionality, performance, clinical use, therapy workflows, availability or customer support. mylife, myLoop, YpsoPump, myOrbit and related brand marks are registered trademarks of mylife Diabetes Care AG or of its affiliates.